''''IMRIS Inc. (TSX: IM) ('IMRIS' or the 'Company') today announced that it has received clearance from Australia's TherapeuticGoodsAdministration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia. IMRISNV ...'